Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Virus Diseases 1Tumor Virus Infections 1Pharyngeal Diseases 1Papillomavirus Infections 1Otorhinolaryngologic Neoplasms 1Otorhinolaryngologic Diseases 1Oropharyngeal Neoplasms 1Neoplasms, Squamous Cell 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Head and Neck Neoplasms 1DNA Virus Infections 1Carcinoma, Squamous Cell 1Carcinoma 1

Interventions

Cyclophosphamide 4Gemcitabine 3isatuximab 2entrectinib 2cobimetinib 2capmatinib 2atezolizumab 2anlotinib 2alectinib 2Vemurafenib 2Sunitinib 2Rituximab 2Lenalidomide 2Dexamethasone 2Cisplatin 2trametinib 1spartalizumab 1pomalidomide 1pertuzumab 1penpulimab 1pembrolizumab 1olaparib 1niraparib 1lutetium Lu 177 dotatate 1ibritumomab tiuxetan 1fludarabine 1dabrafenib 1copper dotatate CU-64 1Trastuzumab 1Taxes 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasms by Histologic Type × Nimorazole × Clear all
NCT04124198 2025-12-31

QoLATI

Rigshospitalet, Denmark

Phase NA Active not recruiting
138 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, DNA Virus Infections, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Oropharyngeal Neoplasms, Otorhinolaryngologic Diseases, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Tumor Virus Infections, Virus Diseases, Neoplasms, Squamous Cell, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡